Preventing Pill Mills Through Data Sharing Act

H.R. 1614 A bill to amend the Controlled Substances Act to establish additional registration requirements for prescribers of opioids, and for other purposes; John S. McCain Opioid Addiction Prevention Act S. 724 A bill to amend the Controlled Substances Act to establish additional registration requirements for prescribers of opioids, and for other purposes; John S. McCain Opioid Addiction Prevention Act S.340 CREATES Act of 2019 H.R. 985 FAST Generics Act of 2019 S.640 Phair Pricing Act of 2019 S. 97 Affordable and Safe Prescription Drug Importation Act S. 61 Safe and Affordable Drugs from Canada Act of 2019 H.R. 1034 Phair Pricing Act of 2019 H.R. 965 CREATES Act of 2019 H.R. 1478 Affordable Insulin Act of 2019 H.R. 447 Affordable and Safe Prescription Drug Importation Act H.R. 1499 Protecting Consumer Access to Generic Drugs Act H.R. 3417 The Beneficiary Education Tools, Telehealth, and Extenders Re-authorization Act of 2019 H.R. 2296 Fair Accountability and Innovative Research Drug Pricing (FAIR Drug Pricing) Act of 2019 H.R. 1607 Fairness to Pet Owners Act H.R. 3379 Priced Relief, Innovation, and Competition for Essential Drugs (PRICED) Act H.R. 478 Safe and Affordable Drugs from Canada Act of 2019 H.R. 3 Lower Drug Costs Now Act of 2019 H.R. 275 Medicare Prescription Drug Price Negotiation Act of 2019 H.R. 448 Medicare Drug Price Negotiation Act H.R. 1046 Medicare Negotiation and Competitive Licensing Act of 2019 H.R. 5304 PBM Transparency in Prescription Drug Costs Act H.R. 5172 NOPAIN Act S. 2543 Prescription Drug Pricing Reduction Act of 2019 S. Rept. 116-120 Prescription Drug Pricing Reduction Act of 2019 S. 2247 Phair Relief Act of 2019 S. 3070 Preventing Pill Mills Through Data Sharing Act H.R. 3055 Further Continuing Appropriations Act, 2020, and Further Health Extenders Act of 2019 H.R. 19 Lower Costs, More Cures Act on 2019 S. 3129 Lower Costs, More Cures Act on 2019 H.R. 748 Coronavirus Aid, Relief, and Economic Security Act or the CARES Act H.R. 6573 Help our Heroes Access Medicine Act of 2020 H.R. 6557 MAIL Act S. 3979 A bill to amend title 10, United States Code, to authorize the Secretary of Defense to temporarily waive cost-sharing amounts under the TRICARE pharmacy benefits program during certain declared emergencies. H.R.6395 - William M. (Mac) Thornberry National Defense Authorization Act for Fiscal Year 2021 H.R. 4806 DEBAR Act of 2019 H.R. 3878 Block, Report, and Suspend Suspicious Shipments Act of 2019 H.R. 4812 Ensuring Compliance Against Drug Diversion Act H.R. 4814 Suspicious Order Identification Act of 2019 H.R. 8061 Community Immunity During COVID-19 Act S. 3548 The CARES Act H.R. 6800 The HEROES Act

Client expense: $280,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 1595 - SAFE Banking Act of 2019 (Ed Perlmutter, D-CO-7) H.R.1119 - To amend the Controlled Substances Act to reduce the gap between Federal and State marijuana policy, and for other purposes (Earl Blumenauer, D-OR-3) H.R.2012 - To amend the Controlled Substances Act to provide that Federal law shall not preempt State law (Diana DeGette, D-CO-1) S.2400 - A bill to promote cannabis research, and for other purposes (Dick Durbin, D-IL) H.R.3884 - Marijuana Opportunity Reinvestment and Expungement Act of 2019 (Jerrold Nadler, D-NY-10) H.R.3884 - To decriminalize and deschedule cannabis, to provide for reinvestment in certain persons adversely impacted by the War on Drugs, to provide for expungement of certain cannabis offenses, and for other purposes (Jerrold Nadler, D-NY-10) oSenate version introduced by Kamala Harris, S.2227 H.R.3797 - To amend the Controlled Substances Act to make marijuana accessible for use by qualified marijuana researchers for medical purposes, and for other purposes (Earl Blumenauer, D-OR-3) H.R.4322 - Expanding Cannabis Research and Information Act (Donna Shalala, D-FL-27) H.R.4323 - Marijuana 1-to-3 Act of 2019 - To provide for the rescheduling of marijuana into schedule III of the Controlled Substances Act (Gregory Steube, R-FL-17) S.2979 - A bill to improve drug testing for transportation-related activities (Roger Wicker, R-MS) S.3070 - A bill to modify reporting requirements under the Controlled Substances Act (Dianne Feinstein, D-CA) S.4386 - A bill to decriminalize and reschedule cannabis, to provide for the regulation of cannabis and cannabis products to protect public health and safety, and for other purposes (Tina Smith, D-MN) H.R.8179 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2020 (Kurt Schrader, D-OR-5) H.R.8732 - To modify reporting requirements under the Controlled Substances Act (Kathy Castor, D-FL-14)

Monitor legislation to prevent and reduce prescription drug abuse. Medication Therapy Management. S.988 and H.R. 803, Improving Transparency and Accuracy in Medicare Part D Drug Spending Act, legislation to prohibit Medicare Part D plan sponsors from retroactively reducing payment on clean claims submitted by pharmacies. Pharmaceutical compounding and the implementation of Drug Quality Security Act; S.2686/ H.R. 4814 Suspicious Order Identification Act of 2019; H.R. 3 Elijah E. Cummings Lower Drugs Costs Now Act; S. 2543 Prescription Drug Pricing Reduction Act of 2019; S. 3070 Preventing Pill Mills Through Data Sharing Act

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Legislation to ensure more appropriate general payment amount for drugs and biological under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Average Sales Price (ASP) generally (in the context of Deficit Reduction). Policies to exclude cancer drugs from the sequestration cuts. Removal of safe harbor protection for rebates to plans or PBMs involving prescription pharmaceuticals and creation of new safe harbor protection. International Pricing Index Model. S.2686/ H.R. 4814 Suspicious Order Identification Act of 2019; H.R. 3 Elijah E. Cummings Lower Drugs Costs Now Act; S. 2543 Prescription Drug Pricing Reduction Act of 2019; S. 3070 Preventing Pill Mills Through Data Sharing Act

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 1614 A bill to amend the Controlled Substances Act to establish additional registration requirements for prescribers of opioids, and for other purposes; John S. McCain Opioid Addiction Prevention Act S. 724 A bill to amend the Controlled Substances Act to establish additional registration requirements for prescribers of opioids, and for other purposes; John S. McCain Opioid Addiction Prevention Act S.340 CREATES Act of 2019 H.R. 985 FAST Generics Act of 2019 S.640 Phair Pricing Act of 2019 S. 97 Affordable and Safe Prescription Drug Importation Act S. 61 Safe and Affordable Drugs from Canada Act of 2019 H.R. 1034 Phair Pricing Act of 2019 H.R. 965 CREATES Act of 2019 H.R. 1478 Affordable Insulin Act of 2019 H.R. 447 Affordable and Safe Prescription Drug Importation Act H.R. 1499 Protecting Consumer Access to Generic Drugs Act H.R. 3417 The Beneficiary Education Tools, Telehealth, and Extenders Re-authorization Act of 2019 H.R. 2296 Fair Accountability and Innovative Research Drug Pricing (FAIR Drug Pricing) Act of 2019 H.R. 1607 Fairness to Pet Owners Act H.R. 3379 Priced Relief, Innovation, and Competition for Essential Drugs (PRICED) Act H.R. 478 Safe and Affordable Drugs from Canada Act of 2019 H.R. 3 Lower Drug Costs Now Act of 2019 H.R. 275 Medicare Prescription Drug Price Negotiation Act of 2019 H.R. 448 Medicare Drug Price Negotiation Act H.R. 1046 Medicare Negotiation and Competitive Licensing Act of 2019 H.R. 5304 PBM Transparency in Prescription Drug Costs Act H.R. 5172 NOPAIN Act S. 2543 Prescription Drug Pricing Reduction Act of 2019 S. Rept. 116-120 Prescription Drug Pricing Reduction Act of 2019 S. 2247 Phair Relief Act of 2019 S. 3070 Preventing Pill Mills Through Data Sharing Act H.R. 3055 Further Continuing Appropriations Act, 2020, and Further Health Extenders Act of 2019 H.R. 19 Lower Costs, More Cures Act on 2019 S. 3129 Lower Costs, More Cures Act on 2019 H.R. 748 Coronavirus Aid, Relief, and Economic Security Act or the CARES Act H.R. 6573 Help our Heroes Access Medicine Act of 2020 H.R. 6557 MAIL Act S. 3979 A bill to amend title 10, United States Code, to authorize the Secretary of Defense to temporarily waive cost-sharing amounts under the TRICARE pharmacy benefits program during certain declared emergencies. H.R.6395 - William M. (Mac) Thornberry National Defense Authorization Act for Fiscal Year 2021 H.R. 4806 DEBAR Act of 2019 H.R. 3878 Block, Report, and Suspend Suspicious Shipments Act of 2019 H.R. 4812 Ensuring Compliance Against Drug Diversion Act H.R. 4814 Suspicious Order Identification Act of 2019 H.R. 8061 Community Immunity During COVID-19 Act S. 3548 The CARES Act H.R. 6800 The HEROES Act

H.R. 1614 A bill to amend the Controlled Substances Act to establish additional registration requirements for prescribers of opioids, and for other purposes S. 724 A bill to amend the Controlled Substances Act to establish additional registration requirements for prescribers of opioids, and for other purposes S. 3070 Preventing Pill Mills Through Data Sharing Act

Client expense: $330,000 · Firm income: Not reported

H.R. 1595 - SAFE Banking Act of 2019 (Ed Perlmutter, D-CO-7) , ALL PROVISIONS H.R.1119 - To amend the Controlled Substances Act to reduce the gap between Federal and State marijuana policy, and for other purposes (Earl Blumenauer, D-OR-3) , ALL PROVISIONS H.R.2012 - To amend the Controlled Substances Act to provide that Federal law shall not preempt State law (Diana DeGette, D-CO-1) , ALL PROVISIONS S.2400 - A bill to promote cannabis research, and for other purposes (Dick Durbin, D-IL) , ALL PROVISIONS H.R.3884 - Marijuana Opportunity Reinvestment and Expungement Act of 2019 (Jerrold Nadler, D-NY-10) , ALL PROVISIONS H.R.3884 - To decriminalize and deschedule cannabis, to provide for reinvestment in certain persons adversely impacted by the War on Drugs, to provide for expungement of certain cannabis offenses, and for other purposes (Jerrold Nadler, D-NY-10) , ALL PROVISIONS oSenate version introduced by Kamala Harris, S.2227 H.R.3797 - To amend the Controlled Substances Act to make marijuana accessible for use by qualified marijuana researchers for medical purposes, and for other purposes (Earl Blumenauer, D-OR-3) , ALL PROVISIONS H.R.4322 - Expanding Cannabis Research and Information Act (Donna Shalala, D-FL-27) , ALL PROVISIONS H.R.4323 - Marijuana 1-to-3 Act of 2019 - To provide for the rescheduling of marijuana into schedule III of the Controlled Substances Act (Gregory Steube, R-FL-17) , ALL PROVISIONS S.2979 - A bill to improve drug testing for transportation-related activities (Roger Wicker, R-MS) , ALL PROVISIONS S.3070 - A bill to modify reporting requirements under the Controlled Substances Act (Dianne Feinstein, D-CA) , ALL PROVISIONS S.4386 - A bill to decriminalize and reschedule cannabis, to provide for the regulation of cannabis and cannabis products to protect public health and safety, and for other purposes (Tina Smith, D-MN) , ALL PROVISIONS H.R.8179 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2020 (Kurt Schrader, D-OR-5) , ALL PROVISIONS

H.R. 127, CARERS Act of 2019; H.R. 171, the Legitimate Use of Medical Marihuana Act; H.R. 1845, ALERT Act of 2019; S. 516, Prescription Drug Monitoring Act of 2019; H.R. 1588, Ending Federal Marijuana Prohibition Act of 2019; Implementation of pharmacy provisions of Public Law No: 115-271; Implementation of Hemp provisions of Public Law No: 115-334; H.R. 4810, the Opioid Prescription Verification Act of 2019; S. 3070, the Preventing Pill Mills Through Data Sharing Act; HR 3878, the Block, Report, and Suspend Suspicious Shipments Act of 2019; HR 4812, the Ensuring Compliance Against Drug Diversion Act; HR 4814, the Suspicious Order Identification Act of 2019

Client expense: $330,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), SENATE, Small Business Administration (SBA), Substance Abuse & Mental Health Services Administration (SAMHSA), White House Office

Monitor legislation to prevent and reduce prescription drug abuse. Medication Therapy Management. S.988 and H.R. 803, Improving Transparency and Accuracy in Medicare Part D Drug Spending Act, legislation to prohibit Medicare Part D plan sponsors from retroactively reducing payment on clean claims submitted by pharmacies. Pharmaceutical compounding and the implementation of Drug Quality Security Act; S.2686/ H.R. 4814 Suspicious Order Identification Act of 2019; H.R. 3 Elijah E. Cummings Lower Drugs Costs Now Act; S. 2543 Prescription Drug Pricing Reduction Act of 2019; S. 3070 Preventing Pill Mills Through Data Sharing Act

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Legislation to ensure more appropriate general payment amount for drugs and biological under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Average Sales Price (ASP) generally (in the context of Deficit Reduction). Policies to exclude cancer drugs from the sequestration cuts. Removal of safe harbor protection for rebates to plans or PBMs involving prescription pharmaceuticals and creation of new safe harbor protection. International Pricing Index Model. S.2686/ H.R. 4814 Suspicious Order Identification Act of 2019; H.R. 3 Elijah E. Cummings Lower Drugs Costs Now Act; S. 2543 Prescription Drug Pricing Reduction Act of 2019; S. 3070 Preventing Pill Mills Through Data Sharing Act

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 127, CARERS Act of 2019; H.R. 171, the Legitimate Use of Medical Marihuana Act; H.R. 1845, ALERT Act of 2019; S. 516, Prescription Drug Monitoring Act of 2019; H.R. 1588, Ending Federal Marijuana Prohibition Act of 2019; Implementation of pharmacy provisions of Public Law No: 115-271; Implementation of Hemp provisions of Public Law No: 115-334; H.R. 4810, the Opioid Prescription Verification Act of 2019; S. 3070, the Preventing Pill Mills Through Data Sharing Act

Client expense: $360,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), SENATE, Small Business Administration (SBA), Substance Abuse & Mental Health Services Administration (SAMHSA), White House Office

H.R. 1595 - SAFE Banking Act of 2019 (Ed Perlmutter, D-CO-7) H.R.1119 - To amend the Controlled Substances Act to reduce the gap between Federal and State marijuana policy, and for other purposes (Earl Blumenauer, D-OR-3) H.R.2012 - To amend the Controlled Substances Act to provide that Federal law shall not preempt State law (Diana DeGette, D-CO-1) S.2400 - A bill to promote cannabis research, and for other purposes (Dick Durbin, D-IL) H.R.3884 - Marijuana Opportunity Reinvestment and Expungement Act of 2019 (Jerrold Nadler, D-NY-10) H.R.3884 - To decriminalize and deschedule cannabis, to provide for reinvestment in certain persons adversely impacted by the War on Drugs, to provide for expungement of certain cannabis offenses, and for other purposes (Jerrold Nadler, D-NY-10) oSenate version introduced by Kamala Harris, S.2227 H.R.3797 - To amend the Controlled Substances Act to make marijuana accessible for use by qualified marijuana researchers for medical purposes, and for other purposes (Earl Blumenauer, D-OR-3) H.R.4322 - Expanding Cannabis Research and Information Act (Donna Shalala, D-FL-27) H.R.4323 - Marijuana 1-to-3 Act of 2019 - To provide for the rescheduling of marijuana into schedule III of the Controlled Substances Act (Gregory Steube, R-FL-17) S.2979 - A bill to improve drug testing for transportation-related activities (Roger Wicker, R-MS) S.3070 - A bill to modify reporting requirements under the Controlled Substances Act (Dianne Feinstein, D-CA)

Client expense: $550,000 · Firm income: Not reported

Issues related to ARCOS data and suspicious order record requirements and reporting (S.3070-Preventing Pill Mills Through Data Sharing Act, S. 2686 & H.R. 4814-Suspicious Order Identification Act of 2019, H.R. 3878-Block, Report And Suspend Suspicious Shipments Act of 2020);implementation of Public Law 113-54 (DSCSA).

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 1614 A bill to amend the Controlled Substances Act to establish additional registration requirements for prescribers of opioids, and for other purposes S. 724 A bill to amend the Controlled Substances Act to establish additional registration requirements for prescribers of opioids, and for other purposes S. 3070 Preventing Pill Mills Through Data Sharing Act

Client expense: $700,000 · Firm income: Not reported

H.R. 1614 A bill to amend the Controlled Substances Act to establish additional registration requirements for prescribers of opioids, and for other purposes; John S. McCain Opioid Addiction Prevention Act S. 724 A bill to amend the Controlled Substances Act to establish additional registration requirements for prescribers of opioids, and for other purposes; John S. McCain Opioid Addiction Prevention Act S.340 CREATES Act of 2019 H.R. 985 FAST Generics Act of 2019 S.640 Phair Pricing Act of 2019 S. 97 Affordable and Safe Prescription Drug Importation Act S. 61 Safe and Affordable Drugs from Canada Act of 2019 H.R. 1034 Phair Pricing Act of 2019 H.R. 965 CREATES Act of 2019 H.R. 1478 Affordable Insulin Act of 2019 H.R. 447 Affordable and Safe Prescription Drug Importation Act H.R. 1499 Protecting Consumer Access to Generic Drugs Act H.R. 3417 The Beneficiary Education Tools, Telehealth, and Extenders Re-authorization Act of 2019 H.R. 2296 Fair Accountability and Innovative Research Drug Pricing (FAIR Drug Pricing) Act of 2019 H.R. 1607 Fairness to Pet Owners Act H.R. 3379 Priced Relief, Innovation, and Competition for Essential Drugs (PRICED) Act H.R. 478 Safe and Affordable Drugs from Canada Act of 2019 H.R. 3 Lower Drug Costs Now Act of 2019 H.R. 275 Medicare Prescription Drug Price Negotiation Act of 2019 H.R. 448 Medicare Drug Price Negotiation Act H.R. 1046 Medicare Negotiation and Competitive Licensing Act of 2019 H.R. 5304 PBM Transparency in Prescription Drug Costs Act H.R. 5172 NOPAIN Act S. 2543 Prescription Drug Pricing Reduction Act of 2019 S. Rept. 116-120 Prescription Drug Pricing Reduction Act of 2019 S. 2247 Phair Relief Act of 2019 S. 3070 Preventing Pill Mills Through Data Sharing Act H.R. 3055 Further Continuing Appropriations Act, 2020, and Further Health Extenders Act of 2019 H.R. 19 Lower Costs, More Cures Act on 2019 S. 3129 Lower Costs, More Cures Act on 2019 H.R. 748 Coronavirus Aid, Relief, and Economic Security Act or the CARES Act H.R. 6573 Help our Heroes Access Medicine Act of 2020 H.R. 6557 MAIL Act S. 3979 A bill to amend title 10, United States Code, to authorize the Secretary of Defense to temporarily waive cost-sharing amounts under the TRICARE pharmacy benefits program during certain declared emergencies. H.R.6395 - William M. (Mac) Thornberry National Defense Authorization Act for Fiscal Year 2021

Monitor legislation to prevent and reduce prescription drug abuse. Medication Therapy Management. S.988 and H.R. 803, Improving Transparency and Accuracy in Medicare Part D Drug Spending Act, legislation to prohibit Medicare Part D plan sponsors from retroactively reducing payment on clean claims submitted by pharmacies. Pharmaceutical compounding and the implementation of Drug Quality Security Act; S.2686/ H.R. 4814 Suspicious Order Identification Act of 2019; H.R. 3 Elijah E. Cummings Lower Drugs Costs Now Act; S. 2543 Prescription Drug Pricing Reduction Act of 2019; S. 3070 Preventing Pill Mills Through Data Sharing Act

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Legislation to ensure more appropriate general payment amount for drugs and biological under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Average Sales Price (ASP) generally (in the context of Deficit Reduction). Policies to exclude cancer drugs from the sequestration cuts. Removal of safe harbor protection for rebates to plans or PBMs involving prescription pharmaceuticals and creation of new safe harbor protection. International Pricing Index Model. S.2686/ H.R. 4814 Suspicious Order Identification Act of 2019; H.R. 3 Elijah E. Cummings Lower Drugs Costs Now Act; S. 2543 Prescription Drug Pricing Reduction Act of 2019; S. 3070 Preventing Pill Mills Through Data Sharing Act

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Opioid Abuse - General issues related to opioid abuse (implementation of Public Law 115-271) Issues related to ARCOS data and suspicious order record requirements and reporting (S. 3070, S. 2686, HR 4814) Importation of Prescription Drugs (HR 447, HR 478, HR 1478, S 61, S 97, S 658, S 844, Public Law 108-173) Implementation of Public Law 113-54 (DSCSA) Block, Report, And Suspend Suspicious Shipments Act of 2019 (HR 3878) Preventing Pill Mills Through Data Sharing Act - S. 3070 Suspicious Order Identification Act of 2019 - S. 2686 Suspicious Order Identification Act of 2019 - HR 4814

Client expense: $313,210 · Firm income: Not reported

Government targets: Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 127, CARERS Act of 2019; H.R. 171, the Legitimate Use of Medical Marihuana Act; H.R. 1845, ALERT Act of 2019; S. 516, Prescription Drug Monitoring Act of 2019; H.R. 1588, Ending Federal Marijuana Prohibition Act of 2019; Implementation of pharmacy provisions of Public Law No: 115-271; Implementation of Hemp provisions of Public Law No: 115-334; H.R. 4810, the Opioid Prescription Verification Act of 2019; S. 3070, the Preventing Pill Mills Through Data Sharing Act

Client expense: $440,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), SENATE, Small Business Administration (SBA), Substance Abuse & Mental Health Services Administration (SAMHSA), White House Office

H.R. 1595 - SAFE Banking Act of 2019 (Ed Perlmutter, D-CO-7), ALL PROVISIONS H.R.1119 - To amend the Controlled Substances Act to reduce the gap between Federal and State marijuana policy, and for other purposes (Earl Blumenauer, D-OR-3), ALL PROVISIONS H.R.2012 - To amend the Controlled Substances Act to provide that Federal law shall not preempt State law (Diana DeGette, D-CO-1), ALL PROVISIONS S.2400 - A bill to promote cannabis research, and for other purposes (Dick Durbin, D-IL), ALL PROVISIONS H.R.3884 - Marijuana Opportunity Reinvestment and Expungement Act of 2019 (Jerrold Nadler, D-NY-10), ALL PROVISIONS H.R.3884 - To decriminalize and deschedule cannabis, to provide for reinvestment in certain persons adversely impacted by the War on Drugs, to provide for expungement of certain cannabis offenses, and for other purposes (Jerrold Nadler, D-NY-10), ALL PROVISIONS oSenate version introduced by Kamala Harris, S.2227, ALL PROVISIONS H.R.3797 - To amend the Controlled Substances Act to make marijuana accessible for use by qualified marijuana researchers for medical purposes, and for other purposes (Earl Blumenauer, D-OR-3), ALL PROVISIONS H.R.4322 - Expanding Cannabis Research and Information Act (Donna Shalala, D-FL-27), ALL PROVISIONS H.R.4323 - Marijuana 1-to-3 Act of 2019 - To provide for the rescheduling of marijuana into schedule III of the Controlled Substances Act (Gregory Steube, R-FL-17), ALL PROVISIONS S.2979 - A bill to improve drug testing for transportation-related activities (Roger Wicker, R-MS), ALL PROVISIONS S.3070 - A bill to modify reporting requirements under the Controlled Substances Act (Dianne Feinstein, D-CA), ALL PROVISIONS

Client expense: $530,000 · Firm income: Not reported

H.R. 1614 A bill to amend the Controlled Substances Act to establish additional registration requirements for prescribers of opioids, and for other purposes; John S. McCain Opioid Addiction Prevention Act S. 724 A bill to amend the Controlled Substances Act to establish additional registration requirements for prescribers of opioids, and for other purposes; John S. McCain Opioid Addiction Prevention Act S.340 CREATES Act of 2019 H.R. 985 FAST Generics Act of 2019 S.640 Phair Pricing Act of 2019 S. 97 Affordable and Safe Prescription Drug Importation Act S. 61 Safe and Affordable Drugs from Canada Act of 2019 H.R. 1034 Phair Pricing Act of 2019 H.R. 965 CREATES Act of 2019 H.R. 1478 Affordable Insulin Act of 2019 H.R. 447 Affordable and Safe Prescription Drug Importation Act H.R. 1499 Protecting Consumer Access to Generic Drugs Act H.R. 3417 The Beneficiary Education Tools, Telehealth, and Extenders Re-authorization Act of 2019 H.R. 2296 Fair Accountability and Innovative Research Drug Pricing (FAIR Drug Pricing) Act of 2019 H.R. 1607 Fairness to Pet Owners Act H.R. 3379 Priced Relief, Innovation, and Competition for Essential Drugs (PRICED) Act H.R. 478 Safe and Affordable Drugs from Canada Act of 2019 H.R. 3 Lower Drug Costs Now Act of 2019 H.R. 275 Medicare Prescription Drug Price Negotiation Act of 2019 H.R. 448 Medicare Drug Price Negotiation Act H.R. 1046 Medicare Negotiation and Competitive Licensing Act of 2019 H.R. 5304 PBM Transparency in Prescription Drug Costs Act H.R. 5172 NOPAIN Act S. 2543 Prescription Drug Pricing Reduction Act of 2019 S. Rept. 116-120 Prescription Drug Pricing Reduction Act of 2019 S. 2247 Phair Relief Act of 2019 S. 3070 Preventing Pill Mills Through Data Sharing Act H.R. 3055 Further Continuing Appropriations Act, 2020, and Further Health Extenders Act of 2019 H.R. 19 Lower Costs, More Cures Act on 2019 S. 3129 Lower Costs, More Cures Act on 2019 H.R. 748 Coronavirus Aid, Relief, and Economic Security Act or the CARES Act

H.R. 1614 A bill to amend the Controlled Substances Act to establish additional registration requirements for prescribers of opioids, and for other purposes S. 724 A bill to amend the Controlled Substances Act to establish additional registration requirements for prescribers of opioids, and for other purposes S. 3070 Preventing Pill Mills Through Data Sharing Act

Client expense: $460,000 · Firm income: Not reported

Issues related to ARCOS data and suspicious order record requirements and reporting (S.3070-Preventing Pill Mills Through Data Sharing Act, S. 2686 & H.R. 4814-Suspicious Order Identification Act of 2019); importation of prescription drugs (HR 447, HR 478, HR 1478, S 61, S 97, S 658, S 844); implementation of Public Law 113-54 (DSCSA).

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Monitor legislation to prevent and reduce prescription drug abuse. Medication Therapy Management. S.988 and H.R. 803, Improving Transparency and Accuracy in Medicare Part D Drug Spending Act, legislation to prohibit Medicare Part D plan sponsors from retroactively reducing payment on clean claims submitted by pharmacies. Pharmaceutical compounding and the implementation of Drug Quality Security Act; S.2686/ H.R. 4814 Suspicious Order Identification Act of 2019; H.R. 3 Elijah E. Cummings Lower Drugs Costs Now Act; S. 2543 Prescription Drug Pricing Reduction Act of 2019; S. 3070 Preventing Pill Mills Through Data Sharing Act

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Legislation to ensure more appropriate general payment amount for drugs and biological under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Average Sales Price (ASP) generally (in the context of Deficit Reduction). Policies to exclude cancer drugs from the sequestration cuts. Removal of safe harbor protection for rebates to plans or PBMs involving prescription pharmaceuticals and creation of new safe harbor protection. International Pricing Index Model. S.2686/ H.R. 4814 Suspicious Order Identification Act of 2019; H.R. 3 Elijah E. Cummings Lower Drugs Costs Now Act; S. 2543 Prescription Drug Pricing Reduction Act of 2019; S. 3070 Preventing Pill Mills Through Data Sharing Act

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 127, CARERS Act of 2019; H.R. 171, the Legitimate Use of Medical Marihuana Act; H.R. 1845, ALERT Act of 2019; S. 516, Prescription Drug Monitoring Act of 2019; H.R. 1588, Ending Federal Marijuana Prohibition Act of 2019; Implementation of pharmacy provisions of Public Law No: 115-271; Implementation of Hemp provisions of Public Law No: 115-334; H.R. 4810, the Opioid Prescription Verification Act of 2019; S. 3070, the Preventing Pill Mills Through Data Sharing Act

Client expense: $280,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), SENATE, Small Business Administration (SBA), Substance Abuse & Mental Health Services Administration (SAMHSA), White House Office

H.R. 1595 - SAFE Banking Act of 2019 (Ed Perlmutter, D-CO-7) , ALL PROVISIONS H.R.1119 - To amend the Controlled Substances Act to reduce the gap between Federal and State marijuana policy, and for other purposes (Earl Blumenauer, D-OR-3) , ALL PROVISIONS H.R.2012 - To amend the Controlled Substances Act to provide that Federal law shall not preempt State law (Diana DeGette, D-CO-1) , ALL PROVISIONS S.2400 - A bill to promote cannabis research, and for other purposes (Dick Durbin, D-IL) , ALL PROVISIONS H.R.3884 - Marijuana Opportunity Reinvestment and Expungement Act of 2019 (Jerrold Nadler, D-NY-10) , ALL PROVISIONS H.R.3884 - To decriminalize and deschedule cannabis, to provide for reinvestment in certain persons adversely impacted by the War on Drugs, to provide for expungement of certain cannabis offenses, and for other purposes (Jerrold Nadler, D-NY-10) , ALL PROVISIONS oSenate version introduced by Kamala Harris, S.2227 H.R.3797 - To amend the Controlled Substances Act to make marijuana accessible for use by qualified marijuana researchers for medical purposes, and for other purposes (Earl Blumenauer, D-OR-3) , ALL PROVISIONS H.R.4322 - Expanding Cannabis Research and Information Act (Donna Shalala, D-FL-27) , ALL PROVISIONS H.R.4323 - Marijuana 1-to-3 Act of 2019 - To provide for the rescheduling of marijuana into schedule III of the Controlled Substances Act (Gregory Steube, R-FL-17) , ALL PROVISIONS S.2979 - A bill to improve drug testing for transportation-related activities (Roger Wicker, R-MS) , ALL PROVISIONS S.3070 - A bill to modify reporting requirements under the Controlled Substances Act (Dianne Feinstein, D-CA) , ALL PROVISIONS

Client expense: $490,000 · Firm income: Not reported

Issues related to ARCOS data and suspicious order record requirements and reporting: S.3070-Preventing Pill Mills Through Data Sharing Act; S. 2686 & H.R. 4814-Suspicious Order Identification Act of 2019;importation of prescription drugs (HR 447, HR 478, HR 1478, S 61, S 97, S 658, S 844); implementation of Public Law 113-54 (DSCSA).

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Opioid Abuse - General issues related to opioid abuse (implementation of Public Law 115-271) Issues related to ARCOS data and suspicious order record requirements and reporting (S. 3070, S. 2686, HR 4814) Importation of Prescription Drugs (HR 447, HR 478, HR 1478, S 61, S 97, S 658, S 844, Public Law 108-173) Implementation of Public Law 113-54 (DSCSA) Block, Report, And Suspend Suspicious Shipments Act of 2019 (HR 3878) Preventing Pill Mills Through Data Sharing Act - S. 3070 Suspicious Order Identification Act of 2019 - S. 2686 Suspicious Order Identification Act of 2019 - HR 4814

Client expense: $314,777 · Firm income: Not reported

Government targets: Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 1614 A bill to amend the Controlled Substances Act to establish additional registration requirements for prescribers of opioids, and for other purposes; John S. McCain Opioid Addiction Prevention Act S. 724 A bill to amend the Controlled Substances Act to establish additional registration requirements for prescribers of opioids, and for other purposes; John S. McCain Opioid Addiction Prevention Act S.340 CREATES Act of 2019 H.R. 985 FAST Generics Act of 2019 S.640 Phair Pricing Act of 2019 S. 97 Affordable and Safe Prescription Drug Importation Act S. 61 Safe and Affordable Drugs from Canada Act of 2019 H.R. 1034 Phair Pricing Act of 2019 H.R. 965 CREATES Act of 2019 H.R. 1478 Affordable Insulin Act of 2019 H.R. 447 Affordable and Safe Prescription Drug Importation Act H.R. 1499 Protecting Consumer Access to Generic Drugs Act H.R. 3417 The Beneficiary Education Tools, Telehealth, and Extenders Re-authorization Act of 2019 H.R. 2296 Fair Accountability and Innovative Research Drug Pricing (FAIR Drug Pricing) Act of 2019 H.R. 1607 Fairness to Pet Owners Act H.R. 3379 Priced Relief, Innovation, and Competition for Essential Drugs (PRICED) Act H.R. 478 Safe and Affordable Drugs from Canada Act of 2019 H.R. 3 Lower Drug Costs Now Act of 2019 H.R. 275 Medicare Prescription Drug Price Negotiation Act of 2019 H.R. 448 Medicare Drug Price Negotiation Act H.R. 1046 Medicare Negotiation and Competitive Licensing Act of 2019 H.R. 5304 PBM Transparency in Prescription Drug Costs Act H.R. 5172 NOPAIN Act S. 2543 Prescription Drug Pricing Reduction Act of 2019 S. Rept. 116-120 Prescription Drug Pricing Reduction Act of 2019 S. 2247 Phair Relief Act of 2019 S. 3070 Preventing Pill Mills Through Data Sharing Act H.R. 3055 Further Continuing Appropriations Act, 2020, and Further Health Extenders Act of 2019 H.R. 19 Lower Costs, More Cures Act on 2019 S. 3129 Lower Costs, More Cures Act on 2019

H.R. 1614 A bill to amend the Controlled Substances Act to establish additional registration requirements for prescribers of opioids, and for other purposes S. 724 A bill to amend the Controlled Substances Act to establish additional registration requirements for prescribers of opioids, and for other purposes S. 3070 Preventing Pill Mills Through Data Sharing Act

Client expense: $540,000 · Firm income: Not reported